Log In
Print this Print this

mazindol (NLS-1)

  Manage Alerts
Collapse Summary General Information
Company NLS Pharma Group
DescriptionControlled-release formulation of a norepinephrine and dopamine reuptake inhibitor
Molecular Target
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today